Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tebonin Forte

Phase 2Small molecule

NNational Neuroscience Institute

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

MCIRecruiting

MCIPhase 2

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 2Recruiting

MCI

NCT04525144

Clinical

Trials by Indication[1]

MCI1 trial

EGb 761 in the Syndrome of MCI With Concomitant CVD

Recruiting·NNational Neuroscience Institute·Phase 2·NCT04525144·134 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tebonin Forte. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tebonin Forte compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tebonin Forte. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Neuroscience Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNational Neuroscience Institute

Related News